PVLA
Palvella Therapeutics, Inc.
NASDAQ · USHealthcareBiotechnology
$124.15-21.04%
Price as of Jul 20, 2026
PVLA valuation
Palvella Therapeutics, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 104.70x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 7.66x
- Price / sales
- —
- Price / cash flow
- -61.19x
Enterprise value
- Enterprise value
- $1.5B
- EV / sales
- —
- EV / EBITDA
- -41.56x
- EV / EBIT
- -33.33x
- Market cap
- $1.8B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.